Reference Listed Drug (RLD) sourcing is a crucial step in the development of generic drugs. In simple terms, an RLD is an already approved drug by a regulatory authority, like the U.S. Food and Drug Administration (FDA), that serves as a comparison for generic drugs. When a company wants to produce a generic drug, it needs to compare it to a Reference-Listed Drug (RLD) to prove that its product is the same in terms of quality, performance, and intended use. This process ensures that generic drugs are safe and effective for consumers.

What are Reference Listed Drugs?

A reference-listed drug is a brand-name drug that serves as a benchmark for evaluating the equivalence of a new generic drug. In other words, it is a well-established medication used as a standard to compare new versions. For example, if a pharmaceutical company is developing a generic version of a popular medication, they will use the original brand-name drug as their reference to ensure that their version is as effective and safe as the original.

Reference Listed Drug sourcing refers to the process of obtaining these approved drugs so that generic drug manufacturers can conduct the necessary tests and studies to develop their versions. The goal is to demonstrate that the generic drug is "bioequivalent" to the RLD, meaning it works in the same way and provides the same benefits as the original.

Reference Listed Drugs- Future of Generic Drugs:  The global generic drug market is expected to reach $574.63 billion by 2030. This growth is attributed to several factors, including the adoption of robotic process automation, the expiration of patents on brand-name drugs, and the rising prevalence of chronic diseases.

When pharmaceutical companies create generic versions of drugs, they must demonstrate that these new versions are bioequivalent to the existing drugs. This means they must perform just as well as the original brand-name drugs. To do this, companies compare their generic drugs to approved drugs called Reference Listed Drugs (RLDs). They must mention these RLDs in their regulatory applications to demonstrate that their generics are equivalent in quality and performance. Ikris Pharma Network (IPN) specializes in sourcing and providing these RLDs worldwide. We have a strong network of trusted suppliers in regions like the EU, USA, Brazil, Korea, Latin America, and Japan. Thanks to this network, we can obtain pharmaceutical products directly and securely, serving the needs of many major pharmaceutical companies globally.

Why is RLD Sourcing Important?

Reference-listed drug or RLD sourcing is crucial for several reasons:

Ensuring Safety and Efficacy: By sourcing a reliable RLD, manufacturers can ensure that their generic version meets the high standards set by regulatory authorities. This is crucial for the safety and efficacy of the drug once it reaches consumers.

Regulatory Compliance: Regulatory agencies like the U.S. Food and Drug Administration (FDA) require that new generic drugs demonstrate equivalence to the reference listed drug. This process helps ensure that generic drugs are reliable and can be substituted for brand-name drugs.

Aids in Regulatory Approval: Using an RLD helps in gaining regulatory approval faster because it provides a proven standard to measure against. If a generic drug can be shown to be the same as the RLD, it is more likely to be approved for sale.

Clinical Trials: In clinical trials, researchers use RLDs to assess the performance of new drugs. For instance, a clinical trial might compare the new drug's effectiveness with that of the reference drug to determine if it performs similarly.

Reduces Development Costs: Sourcing an RLD can significantly cut down the costs and time involved in clinical trials, as the generic manufacturer doesn’t need to prove the drug’s safety and efficacy from scratch.

How is Reference Listed Drug Sourcing Done?

Finding the right reference drug is an important step in drug development. Here's how companies typically source RLDs:

Purchasing from Authorized Suppliers: Pharmaceutical companies often buy RLDs from authorized suppliers. These suppliers have the necessary permissions to sell brand-name drugs for testing and research purposes. This ensures that the drugs are authentic and of high quality.

Collaborating with Wholesalers: Some companies collaborate with wholesalers who specialize in providing RLDs. These wholesalers can access a wide range of medications needed for research.

Importing from Other Countries: In some cases, companies may need to import RLDs from other countries, such as those in Europe, to get the exact version they need. This is especially important when the drug is not available locally.

Our Process of Reference Listed Drug (RLD) Supply:

At Ikris, the Reference Listed Drug (RLD) supply process is straightforward and efficient. It starts with

• Inquiry, where you let us know the specific drug you need.
• Next, we provide a Quotation detailing the cost and terms.
• Once you're satisfied, we move on to the Documentation stage, which ensures all necessary paperwork is completed correctly.
• After that, we proceed with Payment, where you can choose a method that suits you best.
• Finally, we handle the Delivery, which makes sure your RLD reaches you safely and on time.

Our process of RLDs or Clinical Trial Supply is designed to be simple and hassle-free for a seamless experience.

Why You Should Trust Ikris Pharma Network for RLD Sourcing?

Choosing the right partner for RLD sourcing is crucial in the pharmaceutical industry. Ikris Pharma Network (IPN) is a trusted name for many reasons, ensuring you get high-quality products and reliable service.

• Secure Distribution: We are committed to the secure distribution of pharmaceutical products. We ensure that every product we handle is authentic and meets the highest quality standards. Our strict compliance with international regulations guarantees that our RLD or Clinical Trial Drug-sourcing process is transparent and trustworthy.
• Serving Multiple Pharmaceutical Companies: Our network serves many pharmaceutical companies around the world. Whether you're a small business or a large corporation, we have the experience and capacity to meet your needs. We work closely with our clients to ensure they have access to the right reference drugs for their research and development projects.
• EU-GDP Certified Warehouse in Bulgaria and Belgium: We operate EU-GDP (European Union Good Distribution Practice) certified warehouses in Bulgaria and Belgium. This certification means that our facilities meet the stringent standards for handling and distributing pharmaceuticals in the European Union. Our warehouses are equipped to maintain the integrity and quality of your products throughout the distribution process.
• Established and Reliable Network: We boast a well-established network across major markets, including the USA, Canada, UK, Germany, Switzerland, Belgium, Bulgaria, Brazil, France, Japan, China, Netherlands, South Korea, and Australia. This extensive network allows us to source and supply RLDs efficiently and quickly to any part of the world.
• Regular Product Updates: We provide regular product updates to keep our clients informed about the latest developments in RLD or Clinical Trial sourcing. Our team is always available to answer any questions and provide support throughout the sourcing process.
• Logistics for Cold Storage & Shipment: We offer specialized logistics solutions, including cold storage and shipment. We understand the importance of maintaining the right conditions for temperature-sensitive products. Our logistics team ensures that your RLDs are stored and transported in optimal conditions, preserving their quality and efficacy.

In conclusion, reference-listed drug sourcing is essential for ensuring the quality and efficacy of new generic medications. By comparing new drugs to established benchmarks, companies can meet regulatory standards and deliver reliable products. reference-listed drug (RLD) sourcing from Europe, along with other key regions such as the USA, Brazil, Korea, Latin America, and Japan, can be efficiently managed through a network of trusted suppliers. This global approach ensures access to high-quality reference drugs, supporting the development of effective generic alternatives.

Contact us today for a consultation via Email: info@ikrispharmanetwork.com or Mobile: +91 9310 090 915 / +91 8130 290 915.

FAQs

What are Reference Listed Drugs (RLDs), and why are they important in the pharmaceutical sector?

Reference Listed Drugs (RLDs) are brand-name medicines approved by health authorities. They act as a benchmark for creating generic drugs, helping to ensure that these generic versions are safe, effective, and of high quality. RLDs are important because they help the pharmaceutical industry keep drug standards consistent and reliable.

How does Ikris Pharma Network (IPN) ensure a consistent supply of high-quality RLDs for drug development?

Ikris Pharma Network (IPN) builds strong partnerships with reliable RLD suppliers from Europe, the USA, and other important regions. This helps us ensure easy access to high-quality Reference Listed Drugs (RLDs) that meet strict regulations. These trusted connections allow IPN to consistently supply top-notch RLDs to pharmaceutical companies working on new drug development.

How does Ikris obtain RLDs for pharma companies and clinical trials?

Ikris Pharma has built strong partnerships with trusted manufacturers and suppliers globally. We use our extensive network to quickly obtain reference-listed drugs (RLDs) for pharmaceutical companies and clinical trials. Our careful quality checks ensure that the medicines are reliable and meet high standards.

Are you supplying globally?

Yes, our company is dedicated to the global supply of Reference or Innovator drugs. Ikris Pharma Network (IPN) supplies Reference-Listed Drugs in major regions including the USA, Austria, Belgium, Bulgaria, Lithuania, Luxembourg, Croatia, Republic of Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, UAE, Iran, Iraq, Israel, Jordan, Turkey, Afghanistan, Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Brazil, Argentina, Bolivia, South Korea, Japan, and Latin America.

Can Ikris help with the regulatory requirements for RLD supplies?

Yes, Ikris offers help with regulatory needs for suppliers of reference-listed drugs (RLDs). Our team of experts understands pharmaceutical regulations and can assist companies in meeting the necessary standards for using RLDs in their products or clinical studies. We make sure that companies can follow all the rules and use RLDs correctly and efficiently.